{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:08:23Z","timestamp":1740107303835,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00415-022-11115-w","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T17:09:21Z","timestamp":1650042561000},"page":"4802-4807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotype of a second Irish variant causing hereditary amyloidogenic transthyretin amyloidosis"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-9952","authenticated-orcid":false,"given":"Murva","family":"Asad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh","family":"Bermingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisling M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"issue":"9","key":"11115_CR1","doi-asserted-by":"publisher","first-page":"E2403","DOI":"10.1002\/humu.22619","volume":"35","author":"DM Rowczenio","year":"2014","unstructured":"Rowczenio DM, Noor I, Gillmore JD, Lachmann HJ, Whelan C, Hawkins PN, Obici L, Westermark P, Grateau G, Wechalekar AD (2014) Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat 35(9):E2403\u2013E2412","journal-title":"Hum Mutat"},{"doi-asserted-by":"publisher","unstructured":"Manganelli F, Fabrizi GM, Luigetti M, et al (2020) Hereditary transthyretin amyloidosis overview. Neurol Sci. Epub ahead of print. https:\/\/doi.org\/10.1007\/s10072-020-04889-2","key":"11115_CR2","DOI":"10.1007\/s10072-020-04889-2"},{"key":"11115_CR3","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2215\/CJN.08720811","volume":"7","author":"L Lobato","year":"2012","unstructured":"Lobato L, Rocha A (2012) Transthyretin amyloidosis and the kidney. Clin J Am Soc Nephrol 7:1337\u20131346","journal-title":"Clin J Am Soc Nephrol"},{"key":"11115_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/08820538.2019.1687738","volume":"35","author":"R Dammacco","year":"2020","unstructured":"Dammacco R, Merlini G, Lisch W, Kivel\u00e4 TT, Giancipoli E, Vacca A, Dammacco F (2020) Amyloidosis and ocular involvement: an overview. Semin Ophthalmol 35:7\u201326","journal-title":"Semin Ophthalmol"},{"key":"11115_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.wneu.2017.12.096","volume":"111","author":"F Mathieu","year":"2018","unstructured":"Mathieu F, Morgan E, So J, Munoz DG, Mason W, Kongkham P (2018) Oculoleptomeningeal amyloidosis secondary to the rare transthyretin c.381T>G (p.Ile127Met) mutation. World Neurosurg 111:190\u2013193","journal-title":"World Neurosurg"},{"issue":"1","key":"11115_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1185\/03007995.2012.754348","volume":"29","author":"T Coelho","year":"2013","unstructured":"Coelho T, Maurer MS, Suhr OB (2013) THAOS\u2014the transthyretin amyloidosis outcomes survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin 29(1):63\u201376","journal-title":"Curr Med Res Opin"},{"key":"11115_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jnnp.59.1.45","volume":"59","author":"MM Reilly","year":"1995","unstructured":"Reilly MM, Staunton H, Harding AE (1995) Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study. J Neurol Neurosurg Psychiatry 59:45\u201349","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"11115_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3109\/13506129.2014.987377","volume":"22","author":"VH Jimenez-Zepeda","year":"2015","unstructured":"Jimenez-Zepeda VH, Bahlis NJ, Gilbertson J, Rendell N, Porcari R, Lachmann HJ, Gillmore JD, Hawkins PN, Rowczenio DM (2015) A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred. Amyloid. 22(1):26\u201330","journal-title":"Amyloid."},{"issue":"6","key":"11115_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"J Gillmore","year":"2021","unstructured":"Gillmore J, Gane E, Taubel J, Kao J, Fontana M, Maitland M et al (2021) CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N Engl J Med 385(6):493\u2013502","journal-title":"N Engl J Med"},{"issue":"3","key":"11115_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ejhf.1742","volume":"22","author":"A Milandri","year":"2020","unstructured":"Milandri A, Farioli A, Gagliardi C, Longhi S, Salvi F, Curti S, Foffi S, Caponetti AG, Lorenzini M, Ferlini A, Rimessi P, Mattioli S, Violante FS, Rapezzi C (2020) Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies. Eur J Heart Fail 22(3):507\u2013515","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"11115_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","volume":"74","author":"EL Fosb\u00f8l","year":"2019","unstructured":"Fosb\u00f8l EL, R\u00f8rth R, Leicht BP, Schou M, Maurer MS, Kristensen SL, Kober L, Gustafsson F (2019) Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes. J Am Coll Cardiol 74(1):15\u201323","journal-title":"J Am Coll Cardiol"},{"key":"11115_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD et al (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379:11","journal-title":"N Engl J Med"},{"key":"11115_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1716793","volume":"379","author":"MD Benson","year":"2018","unstructured":"Benson MD, Waddington-Cruz M, Berk JL et al (2018) Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med 379:22","journal-title":"N Engl J Med"},{"key":"11115_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","volume":"29","author":"Y Parman","year":"2016","unstructured":"Parman Y, Adams D, Obici L, Gal\u00e1n L, Guergueltcheva V, Suhr OB, Coelho T, European Network for TTR-FAP (ATTReuNET) (2016) Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol 29:S3\u2013S13","journal-title":"Curr Opin Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11115-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11115-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11115-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T15:07:32Z","timestamp":1660057652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11115-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["11115"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11115-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No known conflicts of interest associated with this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from subjects described.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}